Healthcare stocks are moderately lower, with the NYSE Healthcare
Sector Index declining 0.4% and shares of healthcare companies in
the S&P 500 off nearly 0.5% as a group.

In company news, surgical-device maker Synergetics USA (
SURG
) is down nearly 8% at $4.60 a share, paring a portion of its
earlier losses after announcing plans to close its manufacturing
facility in King of Prussia, Penn., and consolidate those
operations into its existing facility in O'Fallon, Mo., by the end
of 2014.

The King of Prussia facility manufactures bipolar
electrosurgical generators, including the neurosurgical,
pain-control and related irrigation units, representing about 11%
of FY13 revenue. It currently employs 24 workers.

Closing activities are expected to cost around $900,000 over the
next 14 months while reducing operating expenses over $1 million
each year beginning in FY16.

SURG also last night announced GAAP earnings of $0.06 per share,
down from a $0.08 profit in the year-ago quarter and matching the
Capital IQ consensus. Revenue rose 5.9% year over year to $17.9
million, beating expectations by nearly $900,000.

In other sector news,

(+) DCTH, (+96.8%) FDA grants orphan drug designation for the
company's melphalan hydrochloride medication to treat a form of
liver cancer. Melphalan for use with the Delcath Hepatic Delivery
System currently is not approved in the U.S.

Please note that once you make your selection, it will apply to all future visits to NASDAQ.com.
If, at any time, you are interested in reverting to our default settings, please select Default Setting above.

If you have any questions or encounter any issues in changing your default settings, please email isfeedback@nasdaq.com.

Please confirm your selection:

You have selected to change your default setting for the Quote Search. This will now be your default target page;
unless you change your configuration again, or you delete your
cookies. Are you sure you want to change your settings?